Atrophy

Slide 1 · Atrophy

Cellular adaptation • Morphology • Clinicopathologic interpretation

Reduced tissue mass • Cellular adaptation • Functional consequences

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Define atrophy and distinguish reduced cell size from loss of cells.

Explain the six major causes of pathologic atrophy.

Relate cellular shrinkage to reduced synthesis, degradation and autophagy.

Interpret tissue morphology and determine when cell loss becomes irreversible.

Slide 3 · Atrophy within the spectrum of cellular adaptation

Adaptations alter cell size, number or phenotype in response to changed demands.

Atrophy reduces organ mass, whereas hypertrophy and hyperplasia increase it.

An adaptive response can preserve surviving cells but compromise organ function.

Normal cell

Atrophic cell

Reduced cytoplasmic volume and organelles

Schematic — not histology

Slide 4 · What is atrophy?

An organ or tissue becomes smaller because its constituent cells shrink and/or decrease in number.

The word describes a morphologic response, not a single disease or molecular pathway.

Atrophy may occur during normal development or under pathologic stress.

Preserved cellular mass

Reduced tissue volume

Schematic: Cell-size and cell-number effects

Slide 5 · Cell shrinkage and cell loss are distinct components

Loss of cytoplasm and intracellular structures decreases individual cell volume.

Cell loss, including apoptosis in some settings, further reduces tissue mass.

The relative importance of these components depends on cause and duration.

Normal cell

Atrophic cell

Reduced cytoplasmic volume and organelles

Schematic — not histology

Slide 6 · Atrophy is an active adaptation

Cells facing fewer resources can reduce their biosynthetic and maintenance demands.

Smaller cells require less energy and fewer intracellular components.

Early atrophy can preserve cell survival despite diminished specialized function.

Nutrient / trophic supply

Protein and organelle mass ↓

Metabolic demand ↓

Adaptation can sustain viability despite loss of function

Slide 7 · Atrophy can be physiologic or pathologic

Physiologic atrophy accompanies programmed changes in normal development.

Pathologic atrophy follows loss of workload, blood supply, nutrition or trophic support.

Interpret size reduction in its developmental, clinical and tissue context.

Preserved cellular mass

Reduced tissue volume

Schematic: Cell-size and cell-number effects

Slide 8 · Physiologic regression during development

Normal embryonic structures are not all retained in mature anatomy.

The notochord and thyroglossal duct as examples of developmental atrophy.

Regression in the expected developmental period is not itself evidence of disease.

Transient embryonic structure

Expected developmental regression

Generic schematic — not embryologic anatomy

Slide 9 · Local and generalized patterns of atrophy

A local insult may selectively affect one muscle, organ or compressed tissue region.

Systemic nutrient deficiency or prolonged inactivity can affect multiple muscle groups.

Distribution is often a stronger etiologic clue than organ size alone.

Disuse

Denervation

Chronic ischemia

Malnutrition

Hormone loss

Pressure

Six cause groups

Slide 10 · The six causes of pathologic atrophy

Disuse and denervation reduce support for skeletal muscle.

Chronic ischemia and malnutrition limit metabolic resources.

Endocrine withdrawal and sustained pressure remove trophic input or impair perfusion.

Disuse

Denervation

Chronic ischemia

Malnutrition

Hormone loss

Pressure

Six cause groups

Slide 11 · Disuse atrophy: A falling mechanical demand

Immobilization in a cast removes usual workload from skeletal muscle.

Complete bed rest similarly reduces the stimuli sustaining muscle mass.

The resulting decrease in fiber size is an adaptive response to disuse.

Normal fibers

Atrophic fibers

Schematic — not a muscle biopsy

Slide 12 · Disuse: The early structural response

Skeletal muscle fibers become smaller before substantial fiber loss develops.

This early decrease in cell size as reversible after activity resumes.

Reversibility depends on timing and the persistence of underlying conditions.

Normal fibers

Atrophic fibers

Schematic — not a muscle biopsy

Slide 13 · Disuse: Progression with prolonged inactivity

Persistent unloading can reduce the number of muscle fibers as well as their size.

Apoptosis contributes to the fiber loss described with prolonged disuse.

Structural loss limits the assumption that all muscle wasting is promptly reversible.

Normal fibers

Atrophic fibers

Schematic — not a muscle biopsy

Slide 14 · Disuse also affects bone

Loss of mechanical loading increases bone resorption in the disuse setting.

Muscle wasting and disuse osteoporosis can therefore coexist.

A casted limb may show coupled consequences in muscle and bone rather than an isolated muscle response.

Mechanical unloading

Muscle fiber

Atrophy

Bone resorption

Increases

Two consequences of sustained disuse

Slide 15 · Cast immobilization and bed rest: Shared principles

A cast causes regional reduction of mechanical work in immobilized muscles.

Bed rest affects a broader distribution because many muscles are unloaded.

Both share reduced demand, but the anatomic distribution differs.

Normal fibers

Atrophic fibers

Schematic — not a muscle biopsy

Slide 16 · Disuse atrophy: Consequences for function

Reduced muscle fiber mass lowers the tissue available for contraction.

Weakness may become evident during remobilization after prolonged unloading.

Functional recovery is a separate question from restoration of gross muscle size.

Normal fibers

Atrophic fibers

Schematic — not a muscle biopsy

Slide 17 · Denervation atrophy: Lost neural support

Skeletal muscle metabolism and function depend on an intact nerve supply.

Damage to the supplying nerve can produce atrophy in its target fibers.

The primary insult is neural rather than a direct loss of muscle workload.

Motor neuron

Axonal innervation

Muscle trophic support

Interruption of this chain may cause atrophy

Slide 18 · The distribution of denervation is informative

Muscles supplied by an injured nerve are preferentially affected.

Mapping weakness and wasting to a nerve distribution can identify the level of pathology.

This contrasts with the more load-related distribution expected in disuse.

Motor neuron

Axonal innervation

Muscle trophic support

Interruption of this chain may cause atrophy

Slide 19 · Disuse and denervation: Similar outcome, different origin

Both can produce smaller skeletal muscle fibers and reduced strength.

Disuse begins with reduced mechanical activation; Denervation begins with disrupted nerve supply.

The clinical context determines which mechanism should be investigated.

Normal fibers

Atrophic fibers

Schematic — not a muscle biopsy

Slide 20 · Chronic ischemia: Slow nutrient and oxygen limitation

Gradually progressive arterial occlusive disease may chronically limit tissue perfusion.

Cells reduce their metabolic requirements in response to sustained supply restriction.

Tissue atrophy may precede irreversible ischemic injury when the reduction is gradual.

Uncompromised lumen

Narrowed lumen

Gradual flow limitation → cellular adaptation

Simplified vessel cross-section

Slide 21 · Chronic ischemia differs from acute destructive injury

Atrophy represents a slower process in which reduced cell mass can temporarily permit survival.

A sufficiently severe or persistent perfusion deficit eventually overwhelms adaptation.

Cell death may then contribute to permanent loss of tissue substance.

Uncompromised lumen

Narrowed lumen

Gradual flow limitation → cellular adaptation

Simplified vessel cross-section

Slide 22 · Brain atrophy in chronic vascular disease

An atrophic brain associated with atherosclerotic cerebrovascular disease.

Reduced blood supply is the proposed underlying stress in that textbook example.

This illustration should not be interpreted as proof that every atrophic brain has one cause.

Normal cortical folds

Atrophy: Narrowed gyri, widened sulci

Schematic — not a brain specimen

Slide 23 · Macroscopic appearance of cerebral atrophy

Loss of cerebral substance makes cortical gyri narrower.

Sulci become wider as the intervening brain parenchyma is lost.

These surface changes are morphologic signs; Cause requires clinical correlation.

Normal cortical folds

Atrophy: Narrowed gyri, widened sulci

Schematic — not a brain specimen

Slide 24 · Why widened sulci matter morphologically

Sulci occupy the spaces between adjacent cortical gyri.

When gyri lose tissue volume, intervening grooves appear more prominent.

Morphologic interpretation relies on changed relationships, not on color or texture alone.

Normal cortical folds

Atrophy: Narrowed gyri, widened sulci

Schematic — not a brain specimen

Slide 25 · Nutritional atrophy: An energy-deficit response

Profound protein–calorie malnutrition eventually depletes stored energy reserves.

Skeletal muscle proteins can be mobilized for energy when other reserves diminish.

Sustained catabolism produces pronounced muscle wasting.

Nutrient / trophic supply

Protein and organelle mass ↓

Metabolic demand ↓

Adaptation can sustain viability despite loss of function

Slide 26 · Marasmus and skeletal muscle loss

Marasmus is the severe undernutrition example specified.

Adipose reserve depletion is followed by use of skeletal muscle protein as fuel.

The principal visible consequence is reduced skeletal muscle mass.

Normal fibers

Atrophic fibers

Schematic — not a muscle biopsy

Slide 27 · Wasting in chronic inflammatory disease

Cachexia may accompany chronic inflammatory diseases and malignancy.

Muscle loss cannot automatically be explained by reduced food intake alone.

Systemic catabolic signals can contribute to loss of muscle proteins and energy reserves.

Nutrient / trophic supply

Protein and organelle mass ↓

Metabolic demand ↓

Adaptation can sustain viability despite loss of function

Slide 28 · Cancer-associated cachexia as an atrophy setting

Cancer-related wasting is one of the catabolic conditions linked to accelerated proteolysis.

Robbins implicates the ubiquitin–proteasome pathway in breakdown of muscle proteins.

A single organ may not adequately represent the systemic burden of tissue wasting.

Protein

Ubiquitin tag

Proteasome

Peptide breakdown products

Simplified ubiquitin–proteasome pathway

Slide 29 · TNF in selected cachectic states

Chronic TNF overproduction as a proposed mediator in some cases.

Reported downstream effects include appetite suppression and lipid depletion.

This is a qualified mechanism, not an assertion that TNF alone explains all cachexia.

TNF overproduction in some cachectic states

Appetite

Suppression

Lipid

Depletion

Can contribute to muscle wasting

Proposed mechanism; Not applicable to every cachexia

Slide 30 · Nutrition-related loss versus disuse

Nutritional atrophy follows inadequate fuel and protein availability.

Disuse atrophy follows loss of normal mechanical demand.

Both can accelerate protein breakdown; The trigger and management context differ.

Normal fibers

Atrophic fibers

Schematic — not a muscle biopsy

Slide 31 · Endocrine withdrawal removes trophic support

Hormone-dependent tissues require stimulation to maintain normal cellular metabolism.

Removing endocrine input can reduce tissue mass and specialized function.

Reproductive tissues and the breast as examples.

Trophic hormone input

Hormone-sensitive tissue

Reduced cell mass after withdrawal

Slide 32 · Postmenopausal atrophy of hormone-responsive tissues

Loss of estrogen stimulation follows the menopausal transition.

Atrophy may affect the endometrium, vaginal epithelium and breast.

This reflects trophic withdrawal, not necessarily a primary vascular lesion.

Trophic hormone input

Hormone-sensitive tissue

Reduced cell mass after withdrawal

Slide 33 · Androgen deprivation and prostatic atrophy

Prostatic tissue responds to androgenic stimulation.

Chemical or surgical castration removes androgen support.

Prostatic atrophy after androgen deprivation in the treatment context of prostate cancer.

Trophic hormone input

Hormone-sensitive tissue

Reduced cell mass after withdrawal

Slide 34 · Apoptosis after endocrine withdrawal

Trophic withdrawal can initially decrease cell size and activity.

Apoptosis contributes to actual cell loss in some endocrine organs after hormone withdrawal.

The resulting organ shrinkage may therefore involve both cellular dimensions and cellularity.

Preserved cellular mass

Reduced tissue volume

Schematic: Cell-size and cell-number effects

Slide 35 · Pressure atrophy: An expanding mass compresses tissue

A benign neoplasm can exert pressure on surrounding non-neoplastic tissue.

Sustained compression may make the adjacent tissue smaller.

The benign character of a lesion does not rule out local tissue damage.

Expanding

Lesion

Compressed

Tissue

Schematic — no specific diagnosis implied

Slide 36 · A proposed vascular mechanism for pressure atrophy

Pressure can compromise perfusion of the compressed region.

Consequent ischemic changes as a probable mechanism.

This is a mechanism proposed for the setting, rather than a universal proven sequence.

Expanding

Lesion

Compressed

Tissue

Schematic — no specific diagnosis implied

Slide 37 · Recognizing pressure atrophy in a specimen

Evaluate tissue immediately adjacent to an enlarging lesion or structure.

Consider whether the surrounding parenchyma has lost volume under sustained compression.

Correlate the geometry with duration and with the expected local blood supply.

Expanding

Lesion

Compressed

Tissue

Schematic — no specific diagnosis implied

Slide 38 · The six causes: Identify the initiating stress

Cause

Initiating disturbance

Textbook example

Disuse

Reduced mechanical work

Cast / bed rest

Denervation

Loss of nerve supply

Nerve damage

Ischemia

Chronically reduced blood supply

Arterial occlusion

Nutrition

Insufficient energetic substrate

Marasmus

Endocrine loss

Withdrawal of trophic hormones

Postmenopause / castration

Pressure

Sustained tissue compression

Expanding benign mass

Slide 39 · Common early cellular response

Atrophic cells reduce their size and intracellular organelle content.

This response is shared across diverse causes despite different initiating stresses.

Reduced cell mass can bring metabolic demand closer to reduced supply.

More organelles

Fewer organelles

Schematic — not an electron micrograph

Slide 40 · Atrophic skeletal muscle: Subcellular simplification

Atrophic muscle cells contain fewer mitochondria.

The quantity of contractile myofilaments is decreased.

Rough endoplasmic reticulum is also reduced, reflecting lower synthetic demand.

More organelles

Fewer organelles

Schematic — not an electron micrograph

Slide 41 · Why organelle loss changes cell physiology

Fewer mitochondria accompany a reduction in the cell’s energy-handling machinery.

Fewer myofilaments correspond to less contractile apparatus.

Reduced rough ER is consistent with attenuated protein biosynthesis.

More organelles

Fewer organelles

Schematic — not an electron micrograph

Slide 42 · A new supply–demand equilibrium

The cell cannot sustain its previous biosynthetic and functional mass under constrained support.

Shrinking intracellular structures lowers the resources needed to maintain viability.

The resulting steady state preserves tissue only at diminished functional capacity.

Nutrient / trophic supply

Protein and organelle mass ↓

Metabolic demand ↓

Adaptation can sustain viability despite loss of function

Slide 43 · Survival and function are not equivalent outcomes

Atrophy can maintain the survival of stressed cells without normal performance.

Early organ dysfunction may therefore exist while cell death remains minimal.

Clinical interpretation should separate reduced function from frank tissue necrosis.

Nutrient / trophic supply

Protein and organelle mass ↓

Metabolic demand ↓

Adaptation can sustain viability despite loss of function

Slide 44 · When adaptive atrophy becomes irreversible

A progressive reduction in blood supply may eventually exceed adaptive capacity.

Cells can become irreversibly injured and die, often by apoptosis’ description.

Late organ atrophy may incorporate permanent cell loss, not just reversible shrinkage.

Preserved cellular mass

Reduced tissue volume

Schematic: Cell-size and cell-number effects

Slide 45 · Protein homeostasis explains changes in cell mass

Atrophy reflects reduced protein synthesis together with increased protein degradation.

These processes shift the balance of cellular protein content toward net loss.

Organellar turnover is an additional component of the atrophic response.

Reduced trophic signaling

Lower protein synthesis

Reduced cell mass

The anabolic side of the balance

Slide 46 · Reduced trophic input decreases protein synthesis

Growth-related signals ordinarily promote nutrient uptake and mRNA translation.

When stimulation falls, the anabolic drive to maintain cell proteins declines.

The cellular proteome and structural mass decrease over time.

Reduced trophic signaling

Lower protein synthesis

Reduced cell mass

The anabolic side of the balance

Slide 47 · The ubiquitin–proteasome system

Ubiquitin ligases attach ubiquitin to selected cellular protein substrates.

Tagged proteins are targeted to proteasomes for degradation.

Nutrient deficiency and disuse are triggers noted for this catabolic route.

Protein

Ubiquitin tag

Proteasome

Peptide breakdown products

Simplified ubiquitin–proteasome pathway

Slide 48 · Proteolysis contributes to muscle wasting

Loss of skeletal muscle protein reduces the intracellular contractile apparatus.

Enhanced proteasomal protein degradation is associated with multiple catabolic conditions.

Cancer-related cachexia is specifically cited as a setting of accelerated proteolysis.

Protein

Ubiquitin tag

Proteasome

Peptide breakdown products

Simplified ubiquitin–proteasome pathway

Slide 49 · Autophagy removes cellular components

Atrophy can be accompanied by increased numbers of autophagic vacuoles.

The pathway supports intracellular digestion of cytoplasmic components and organelles.

This is distinct from proteasomal breakdown of ubiquitin-tagged proteins.

Cargo

Autophagic

Compartment

Fusion /

Degradation

Schematic — not an ultrastructural image

Slide 50 · Protein degradation and organelle recycling are complementary

Feature

Ubiquitin–proteasome

Autophagy

Typical cargo

Ubiquitin-tagged cellular proteins

Cytoplasmic structures and organelles

Atrophy association

Protein breakdown in disuse and catabolism

Increased autophagic vacuoles

Morphologic correlate

Less cellular protein mass

Vacuoles; possible residual bodies

Slide 51 · Undigested residual bodies

Not all autophagic cargo is completely digested.

Indigestible material may remain within membrane-bound cytoplasmic residual bodies.

The residue can persist even when the tissue has otherwise shrunk.

Cargo

Autophagic

Compartment

Fusion /

Degradation

Schematic — not an ultrastructural image

Slide 52 · Lipofuscin and brown atrophy

Lipofuscin is a pigment-containing example of persistent residual material.

When the intracellular granules accumulate sufficiently, tissue may appear brown.

“Brown atrophy” denotes this pigment-associated appearance, not a separate cause of tissue wasting.

Residual brown granules

Schematic — not lipofuscin-stained tissue

Slide 53 · Putting the intracellular mechanisms together

Two concurrent shifts in protein and organelle homeostasis reduce cellular mass.

Reduced trophic support / nutrient availability

Protein synthesis decreases

Proteolysis and autophagy increase

Reduced proteins and organelles → smaller cell

Slide 54 · From cell biology to gross pathology

Decreased cell size reduces organ volume even without immediate cell death.

Additional apoptosis can further reduce cell number and tissue mass.

Gross appearance depends on architecture: For example, narrowed gyri in cerebral atrophy.

Preserved cellular mass

Reduced tissue volume

Schematic: Cell-size and cell-number effects

Slide 55 · Atrophy is not hypoplasia

Atrophy denotes reduction of a previously formed tissue or organ.

Hypoplasia denotes incomplete development of tissue or organ mass.

A history of normal prior development is essential when assigning the term atrophy.

Preserved cellular mass

Reduced tissue volume

Schematic: Cell-size and cell-number effects

Slide 56 · Atrophy is not hypertrophy or hyperplasia

Process

Primary cellular change

Effect on tissue mass

Atrophy

Cell size ↓; sometimes cell number ↓

Usually decreases

Hypertrophy

Cell size ↑

Increases

Hyperplasia

Cell number ↑

Increases

Slide 57 · Atrophy is not synonymous with necrosis

The early atrophic cell is smaller and may remain alive.

Severe or persistent stress can subsequently induce irreversible injury and death.

The presence of a small organ alone cannot establish whether necrosis occurred.

Nutrient / trophic supply

Protein and organelle mass ↓

Metabolic demand ↓

Adaptation can sustain viability despite loss of function

Slide 58 · Reversibility has biologic limits

Early disuse-related reduction in muscle cell size is described as reversible.

Prolonged disuse can lead to muscle fiber loss through apoptosis.

Reversal of the trigger need not restore cells already lost.

Normal fibers

Atrophic fibers

Schematic — not a muscle biopsy

Slide 59 · Clinical reasoning: Start with distribution and exposure

Determine whether the wasting is localized, regional or generalized.

Ask about immobilization, neurologic injury, arterial disease, nutrition and endocrine status.

Identify an adjacent compressive mass when an isolated structure is affected.

Disuse

Denervation

Chronic ischemia

Malnutrition

Hormone loss

Pressure

Six cause groups

Slide 60 · Teaching case: Immobilized limb

A patient undergoes prolonged cast immobilization after a fracture. The immobilized limb is visibly smaller after the cast is removed.

QUESTION

What initiating stimulus and early cellular change best explain this finding?

Interpretation: Disuse: Reduced mechanical workload; Skeletal muscle cells initially become smaller.

Slide 61 · Teaching case: Localized weakness after nerve injury

After an injury to a peripheral nerve, weakness and visible wasting develop mainly in the muscles served by that nerve.

QUESTION

Which category of atrophy is suggested by the anatomic distribution?

Interpretation: Denervation atrophy: Loss of the nerve supply supporting normal muscle metabolism.

Slide 62 · Teaching case: Chronic arterial compromise

A gradually worsening arterial lesion produces prolonged limitation of tissue blood flow; Tissue volume declines over time.

QUESTION

What distinguishes this process from acute ischemic cell death?

Interpretation: Chronic ischemic atrophy can initially lower cell mass and metabolic demand; Worsening supply may later cause irreversible injury.

Slide 63 · Teaching case: Hormone withdrawal

Following loss of hormonal stimulation, a previously functional hormone-sensitive tissue develops a reduced epithelial or parenchymal mass.

QUESTION

Which trophic mechanism is implicated?

Interpretation: Loss of endocrine stimulation, with cellular shrinkage and sometimes apoptosis.

Slide 64 · Teaching case: An enlarging benign mass

A slowly enlarging benign lesion is surrounded by a narrowed rim of otherwise non-neoplastic organ tissue.

QUESTION

Why might normal tissue atrophy even though the mass is benign?

Interpretation: Sustained compression; Probable local ischemia from compromised microvascular supply.

Slide 65 · Atrophy: Synthesis for interpretation

Trace the biologic sequence from the first disturbance to the tissue-level effect.

Identify the initiating stress

Establish cell-size / cell-loss changes

Relate organ morphology to function

Assess reversibility and progression

Interpret each arrow causally; The progression may be slowed or interrupted when the stress is relieved.

Slide 66 · Essential conclusions

Atrophy is a decrease in tissue mass caused by cellular shrinkage, often supplemented by cell loss.

The six causes are disuse, denervation, ischemia, malnutrition, endocrine loss and pressure.

Its shared cellular signature is lower anabolic activity, increased degradation and fewer organelles.

Early adaptation may preserve life; Sustained stress can add irreversible injury and apoptosis.

Normal cell

Atrophic cell

Reduced cytoplasmic volume and organelles

Schematic — not histology

Slide 67 · References and scope

Primary textbook

Robbins, Cotran & Kumar: Pathologic Basis of Disease, 11th edition (2026).

Chapter 2 — Cell Injury, Cell Death, and Adaptations.

Atrophy (pp. 54–55); Mechanisms of Atrophy (p. 55).

Slide schematics are editable conceptual drawings and do not represent authentic gross specimens, histology, or clinical imaging.